/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $1M · -791.09% margin · -$8M FCF
The business is unprofitable at the operating level (-771.64% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 65.5% YoY with margins expanding 827.4pp.
Negative free cash flow of -$7M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$1M
▲ +65.5% YoY
Net Income (TTM)
-$8M
▲ +7.3% YoY
Op. Margin
-791.09%
▲ +827.4pp YoY
ROIC
-159.05%
▲ +9.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$8M
▼ -21.5% YoY
Op. Cash Flow (TTM)
-$8M
▼ -21.3% YoY
Net Debt
-$3M
Net Cash Position
Cash & Equiv.
$3M
3Y CAGR: +65.2%
Continue Research